This news is about some big companies in the medicine world! There were some important updates about drugs and companies buying each other. It's all about how businesses are changing and what it might mean for the future.
- Novo Nordisk's medicine shortage is over!
- Acelyrin might be bought by Concentra Biosciences instead of merging with Alumis.
- Intra-Cellular Therapies, the maker of Caplyta, made a lot of money last year and is being bought by Johnson & Johnson.
| Company | Event | Number |
|---|---|---|
| Novo Nordisk | Shortage resolved | N/A |
| Acelyrin | Takeover bid | $3 per share |
| Intra-Cellular Therapies | Sale to J&J | $15 billion |
| Hims & Hers Health | Stock drop | >20% |
